Skip to Content

5th Annual Bayesian Biostatistics Conference

Sponsored in part by the Department of Biostatistics at The University of Texas MD Anderson Cancer Center

Monday, January 23, 2012 – Wednesday, January 25, 2012

Robert C. Hickey Auditorium
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd, Houston, Texas 77030

Program Committee

  • Donald A. Berry, PhD, Co-Chair; The University of Texas MD Anderson Cancer Center
  • Telba Z. Irony, PhD, Co-Chair; CDRH, U.S. Food and Drug Administration
  • Brenda  L. Gaydos, PhD; Eli Lilly and Company
  • Lurdes Inoue, PhD; University of Washington
  • Jeffrey D. Maca, PhD; Novartis Pharmaceutical
  • Jeffrey S. Morris, PhD; The University of Texas MD Anderson Cancer Center
  • Dalene Stangl, PhD; Duke University

Program Highlights

Short course: Reproducible Research 
Frank E. Harrell, Jr., PhD
Professor and Chair, Department of Biostatistics
Vanderbilt University School of Medicine

Keynote presentation:  Bayesian Adjustment for Multiplicity and Subgroup Analysis (pdf)
James O. Berger, PhD
Arts and Sciences Professor of Statistics
Department of Statistical Science
Duke University

Session Topic: Multiple Comparisons 

Session Topic: Missing Data 

  • Thomas R. Belin, PhD
    Professor of Biostatistics & Psychiatry and Biobehavioral Sciences
    School of Public Health
    University of California at Los Angeles
  • Michael J. Daniels, ScD
    Professor and Chair, Department of Statistics
    University of Florida at Gainesville
  • Treatment discontinuation and missing data in clinical trials: Ignorability and identifiability issues (pdf)
    Roderick Little, PhD
    Richard D. Remington Collegiate Professor of Biostatistics
    Professor, Department of Statistics, School of Public Health
    University of Michigan

Session Topic: Bayesian Methods for Evidence Synthesis to Drive Decision Making in Drug Development 

  • Hajun Ma, PhD
    Senior Statistical Manager
    Global Safety and Independent Biostatistics Group
    Amgen
  • Fanni Natanegara, PhD
    Senior Research Scientist
    Eli Lilly and Company
  • John Scott, PhD
    Statistician
    Center for Biologics Evaluation and Research
    U.S. Food and Drug Administration

Session Topic: Bayesian Methods in Trial Design and Analysis 

  • David Ohlssen, PhD
    Novartis Pharmaceutical
  • William Prucka, PhD
    Eli Lilly and Company

Session Topic: Incorporating Biological Structure in Bayesian Modeling: Networks and Pathway Analysis 

 

 

 

Updated February 9, 2012     

© 2014 The University of Texas MD Anderson Cancer Center